BackAscletis Pharma Overview

Ascletis Pharma Total Assets

Latest total assets for ASCLF: $2.5B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$2.45B
↑ 22.78% YoYΔ $454.79M vs prior year quarter

Peer trimmed avg / median

Loading

Ascletis Pharma Total Assets History

Loading

Ascletis Pharma vs. peers: Total Assets Comparison

Loading

Ascletis Pharma Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascletis Pharma (ASCLF) FAQ

As of the most recent data (June 2026), ASCLF shows a total assets of $2.5B. That compares with $2B in the prior-year period — up 22.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASCLF's total assets is now $2.5B (was $2B) — a 22.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ascletis Pharma is outperforming or lagging.

Tracking ASCLF's total assets over time shows whether Ascletis Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $2.5B That compares with $2B in the prior-year period — up 22.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Ascletis Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $2.5B) with ownership activity and broader fundamentals.

Ascletis Pharma's total assets is $2.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.